NUIG study makes major breakthrough in treatment of aggressive breast cancer

Galway Bay fm newsroom – A research team at NUI Galway has made a major breakthrough in the study of treatment options for triple negative breast cancer. Unlike other forms of the disease, there are no targeted therapies for TNPC which is a very aggressive and difficult to treat condition. Chemotherapy is the primary treatment option, and although initially successful, a large percentage of patients relapse within one to three years. Researchers at NUI Galway have now discovered a new therapy that can significantly increase the effectiveness of the treatment. They identified a cellular stress sensor which helps cancer cells to survive and grow in response to chemotherapy – and also how it can be blocked from doing so. Dr. Susan Logue says the next step will be clinical trials, hear more from her on the 11 bulletin…